This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Hematology, Other  • Alert me on articles by topic

Edited by Junio V. Melo and John M. Goldman, 354 pp, $169.
New York, NY, Springer, 2007.
ISBN-13 978-3-5403-4505-3.

JAMA. 2007;298:343.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

First identified and named by William Dameshek in 1951, myeloproliferative disorders have become "landmarks in the history of malignant disease . . . on which progress in understanding and treating other malignancies . . . and indeed solid tumors can be based." Despite their relative infrequency in ordinary clinical practice, they are not uncommon in hematologic practice. From that perspective, the contributors do not regard this new book to be targeted to any particular audience but that it "should be of interest to medical students who find the specialty of hematology truly fascinating." For other physicians and for patients, this reference provides a needed understanding of avant-garde medical research.

Biospy specimen taken from a 48-year-old man showing tumor composed of cells of the type normally found in bone marrow. Low- and high-power micrographs (top and bottom, respectively) show numerous plasma cells. Photographed at University Hospital, University of California at Irvine. Photograph courtesy of MEDLogic Inc.

The editors have . . . [Full Text of this Article]

William H. Wehrmacher, MD, Reviewer
wwehrmacher@lumc.edu
Stritch School of Medicine
Loyola University Chicago
Maywood, Illinois

Harry L. Messmore, MD, Reviewer
Cardinal Bernardin Cancer Center
Loyola University Chicago